全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2020 

Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature

DOI: https://doi.org/10.1155/2020/8247960

Full-Text   Cite this paper   Add to My Lib

Abstract:

Crizotinib is a first-line tyrosine kinase inhibitor used for the treatment of metastatic lung cancer. Crizotinib-induced hepatotoxicity is a rare event. We report a case of a 46-year-old female with a history of metastatic lung cancer who presented with acute liver failure after being on crizotinib for two months. The medication was discontinued, and she was treated with N-acetylcysteine for seven days. Her liver function tests returned to normal limits after 26 days after admission. The precise mechanism and risk factors of crizotinib-induced hepatotoxicity remain unknown. Physicians should be aware of the potentially lethal side effect caused by crizotinib

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133